A Study for PMS of AZL-M/CLD FDC in the Treatment of Participants With Essential HTN in South Korea
Clinical trial NCT04470830 · COMPLETED
Trial details
- NCT number
- NCT04470830
- Sponsor
- Celltrion Pharm, Inc.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-09-11
- Primary completion
- 2023-05-25
- Enrollment
- 718
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.